Etoposide and dyspnoea Patient Reports February 12, 2012

Etoposide Side Effects Report #5051873-3
Etoposide side effect was reported by a Health Professional from UNITED STATES on July 13, 2006. Male patient, 46 years of age, weighting 167.8 lb, was diagnosed with testis cancer and was treated with Etoposide. After drug was administered, patient experienced the following side effects: chest pain , dyspnoea, feeling hot, flushing, hypersensitivity. Etoposide dosage: IV (525 ML/HR) ONCE DAILY. During the same period patient was treated with ANZEMET, DECADRON. Patient recovered.

Etoposide Side Effects Report #5151982-4
Etoposide side effect was reported by a Health Professional from FRANCE on Oct 26, 2006. Male patient, 32 years of age, was diagnosed with testis cancer and was treated with Etoposide. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anxiety , bradycardia, brain herniation, cerebral ischaemia, chills, dyspnoea, enterococcal infection, escherichia infection. Etoposide dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, LENOGRASTIM. Patient died.

Etoposide Side Effects Report #5335831-7
Etoposide side effect was reported by a Pharmacist from UNITED STATES on Mar 06, 2006. Male patient, 25 years of age, weighting 221.6 lb, was diagnosed with testis cancer and was treated with Etoposide. After drug was administered, patient experienced the following side effects: chest discomfort, dyspnoea. Etoposide dosage: 500 MG DAILY X 5 DAYS, REPEATS CYCLE EVERY THREE WEEKS (217 MG), INTRAVENOUS (NOT OTHERWISE SPECIFIE. During the same period patient was treated with CISPLATIN, VICODIN. Patient recovered.

Etoposide Side Effects Report #6079646-3
Etoposide side effect was reported by a Health Professional from TAIWAN, PROVINCE OF CHINA on Jan 21, 2009. Male patient was diagnosed with rhabdomyosarcoma and was treated with Etoposide. After drug was administered, patient experienced the following side effects: abdominal distension, ascites, blood albumin decreased, blood bicarbonate increased, blood ph increased, dyspnoea, febrile neutropenia, fibrin d dimer increased, hepatomegaly. Etoposide dosage: 100 MG/M2, EVERY 3 WEEKS. During the same period patient was treated with VINCRISTINE SULPHATE, DACTINOMYCIN, IFOSFAMIDE, EPIRUBICIN. Patient recovered.


Etoposide Side Effects Report #4836995-1
Etoposide side effect was reported by a Consumer or non-health professional from FRANCE on Nov 02, 2005. Female patient, 38 years of age, was diagnosed with lymphoma  and was treated with Etoposide. After drug was administered, patient experienced the following side effects: cyanosis, deep vein thrombosis , device related infection, diarrhoea, dyspnoea, groin pain, oral candidiasis, pain in extremity, phlebitis. Etoposide dosage: 210 MILLIGRAM QM, INTRAVENOUS (NOS). During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, MABTHERA, NOMEGESTROL ACETATE, ARANESP, METOCLOPRAMIDE, FERROUS SULPHATE. Patient was hospitalized. Patient recovered.

Etoposide Side Effects Report #5862467-1
Etoposide side effect was reported by a Pharmacist from UNITED STATES on Aug 27, 2008. Male patient, 68 years of age, weighting 227.1 lb, was diagnosed with lung neoplasm malignant and was treated with Etoposide. After drug was administered, patient experienced the following side effects: chest discomfort, dizziness , dyspnoea, hyperhidrosis, hypertension. Etoposide dosage: 6 ML ONCE IV. Patient recovered.

Etoposide Side Effects Report #5689898-7
Etoposide side effect was reported by a Pharmacist from UNITED STATES on Mar 31, 2008. Male patient, 60 years of age, weighting 304.2 lb, was diagnosed with lung neoplasm malignant and was treated with Etoposide. After drug was administered, patient experienced the following side effects: cough, cyanosis, dyspnoea, tachycardia, wheezing. Etoposide dosage: 184MG ONCE IV. Patient recovered.

Etoposide Side Effects Report #4969160-8
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 11, 2005. Male patient, 50 years of age, weighting 196.2 lb, was diagnosed with lung neoplasm malignant and was treated with Etoposide. After drug was administered, patient experienced the following side effects: dyspnoea, flushing. Etoposide dosage: unknown. During the same period patient was treated with CARBOPLATIN, DECADRON, DOLASETRON, NEXIUM, CALCIUM CARBONATE, FLOMAX, FLONASE. Patient recovered.

Etoposide Side Effects Report #4752932-2
Etoposide side effect was reported by a Pharmacist from UNITED STATES on Mar 07, 2005. Male patient was diagnosed with large cell lung cancer stage iii and was treated with Etoposide. After drug was administered, patient experienced the following side effects: dyspnoea, flushing, photopsia, vitreous floaters. Etoposide dosage: 100MG/1/IV. Patient recovered.


Etoposide Side Effects Report #6028050-2
Etoposide side effect was reported by a Physician from GERMANY on Dec 15, 2008. Female patient, 27 years of age, was diagnosed with gestational trophoblastic tumour and was treated with Etoposide. After drug was administered, patient experienced the following side effects: blood albumin decreased, brain oedema, dyspnoea, haemoptysis, hepatic function abnormal, respiratory failure, shock, thrombocytopenia. Etoposide dosage: INTRAVENOUS BOLUS; 100 MG/M2 ( EVERY 12 HOURS X 4 ) INTRAVENOUS. During the same period patient was treated with VINCRISTINE, DACTINOMYCIN, METHOTREXATE, CYCLOPHOSPHAMIDE, METHIMAZOLE, PROPRANOLOL. Patient recovered.

Etoposide Side Effects Report #4672427-4
Etoposide side effect was reported by a Pharmacist from on May 20, 2005. Male patient, 19 years of age, weighting 142.6 lb, was diagnosed with germ cell cancer, metastasis and was treated with Etoposide. After drug was administered, patient experienced the following side effects: anaphylactic reaction, dyspnoea, infusion related reaction, skin discolouration. Etoposide dosage: 175 MG IV QD X 5 D. Patient recovered.

Etoposide Side Effects Report #6005402-8
Etoposide side effect was reported by a Health Professional from UNITED KINGDOM on Dec 12, 2008. Female patient, 61 years of age, was diagnosed with chronic lymphocytic leukaemia, prophylaxis against graft versus host disease and was treated with Etoposide. After drug was administered, patient experienced the following side effects: collapse of lung, dyspnoea, epstein-barr virus associated lymphoproliferative disorder, epstein-barr virus infection, pulmonary hilum mass, pyrexia. Etoposide dosage: unknown. During the same period patient was treated with CARMUSTINE, ALEMTUZUMAB, MELPHALAN, CYTARABINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Etoposide Side Effects Report #6024119-7
Etoposide side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 15, 2008. Female patient, 61 years of age, was diagnosed with chronic lymphocytic leukaemia, prophylaxis against graft versus host disease and was treated with Etoposide. After drug was administered, patient experienced the following side effects: collapse of lung, dyspnoea, epstein-barr virus associated lymphoproliferative disorder, epstein-barr virus infection, pulmonary hilum mass, pyrexia. Etoposide dosage: unknown. During the same period patient was treated with CAMPATH, CARMUSTINE, CYCLOSPORINE, CYTARABINE, MELPHALAN. Patient was hospitalized. Patient recovered.

Etoposide Side Effects Report #5128296-1
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 11, 2006. Female patient, 37 years of age, was diagnosed with choriocarcinoma, metastases to lung and was treated with Etoposide. After drug was administered, patient experienced the following side effects: arthralgia, bone marrow failure, dyspnoea, nephropathy toxic, stomatitis. Etoposide dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOPHOSPHAMIDE, COSMEGEN, VINCRISTINE. Patient recovered.


Etoposide Side Effects Report #5381456-7
Etoposide side effect was reported by a Consumer or non-health professional from NETHERLANDS on July 03, 2007. Male patient, 59 years of age, weighting 145.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Etoposide. After drug was administered, patient experienced the following side effects: atelectasis, blood bilirubin abnormal, bronchospasm, dyspnoea, hepatic function abnormal, hypokalaemia, hyponatraemia, lung infiltration. Etoposide dosage: unknown. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient recovered.

Etoposide Side Effects Report #4864038-2
Etoposide side effect was reported by a Health Professional from UNITED STATES on Dec 12, 2005. Male patient, 44 years of age, was diagnosed with acute myeloid leukaemia and was treated with Etoposide. After drug was administered, patient experienced the following side effects: dyspnoea, gastrointestinal haemorrhage, hepatic failure, pulmonary haemorrhage, renal failure. Etoposide dosage: unknown. During the same period patient was treated with CYTARABINE, MITOXANTRONE. Patient died.

Etoposide Side Effects Report #5648242-1
Etoposide side effect was reported by a Health Professional from NETHERLANDS on Feb 29, 2008. Female patient, weighting 152.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Etoposide. After drug was administered, patient experienced the following side effects: dyspnoea, lymphadenopathy, obstructive airways disorder, tonsillitis. Etoposide dosage: unknown. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, ALDESLEUKIN. Patient was hospitalized. Patient recovered.

Etoposide Side Effects Report #4707395-X
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on July 05, 2005. Male patient, weighting 193.3 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Etoposide. After drug was administered, patient experienced the following side effects: confusional state, dyspnoea, graft versus host disease, hypoxia, obliterative bronchiolitis, tachycardia. Etoposide dosage: 100MG/M2 IV OVER 1 HR ON DAY (-3).. During the same period patient was treated with ALLOGINIC BONE MARROW CELLS, ALFA. Patient recovered.

Etoposide Side Effects Report #4707864-2
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on July 05, 2005. Male patient, weighting 193.3 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Etoposide. After drug was administered, patient experienced the following side effects: confusional state, dyspnoea, graft versus host disease, hypoxia, obliterative bronchiolitis, post procedural complication, tachycardia. Etoposide dosage: 100 MG/M2 IV OVER 1 HR ON DAY (-3).. During the same period patient was treated with ALLOGENIC BONE MARROW CELLS, ALFA, IRRADIATION. Patient was hospitalized. Patient recovered.


Etoposide Side Effects Report #4959688-9
Etoposide side effect was reported by a Health Professional from UNITED STATES on Mar 29, 2006. Male patient, 71 years of age, was diagnosed with hypersensitivity and was treated with Etoposide. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, febrile neutropenia. Etoposide dosage: unknown. During the same period patient was treated with CISPLATIN, IRINOTECAN, VITAMIN, ASCORBIC ACID, VITAMIN B, PRIMATENE, ALEVE, EXCEDRIN. Patient was hospitalized. Patient died on 01/28/2006.

Etoposide Side Effects Report #4971534-6
Etoposide side effect was reported by a Physician from UNITED STATES on Mar 30, 2006. Male patient, 71 years of age, was treated with Etoposide. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, febrile neutropenia. Etoposide dosage: 60 MG/M*2,. During the same period patient was treated with IRINOTECAN, CISPLATIN, VITAMIN, ASCORBIC ACID, CYANOCOBALAMIN, PRIMATENE, ALEVE. Patient died on 01/28/2006.

Etoposide Side Effects Report #5569785-5
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 04, 2007. Female patient, 66 years of age, weighting 231.5 lb, was treated with Etoposide. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, dyspnoea, fatigue, malaise. Etoposide dosage: 100MG/M2. Patient died on 09/24/2007.

Etoposide Side Effects Report #5699146-X
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2007. Male patient, 64 years of age, was treated with Etoposide. After drug was administered, patient experienced the following side effects: dyspnoea, throat tightness. Etoposide dosage: 180 MG OVER 2 HOUR VIA IV INFUSION, INTRAVENOUS DRIP. During the same period patient was treated with CARBOPLATIN, ONDANSETRON. Patient recovered.

Etoposide Side Effects Report #5866439-2
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2007. Male patient, 64 years of age, was treated with Etoposide. After drug was administered, patient experienced the following side effects: dyspnoea, throat tightness. Etoposide dosage: 180 MG, OVER TWO HOURS, INTRANVEOUS DRIP. During the same period patient was treated with CARBOPLATIN, ONDANSETRON. Patient recovered.


Etoposide Side Effects Report #4752929-2
Etoposide side effect was reported by a Physician from UNITED STATES on Oct 15, 2004. Female patient, 60 years of age, was treated with Etoposide. After drug was administered, patient experienced the following side effects: back pain , dyspnoea, hypotension. Etoposide dosage: 100 MG/M2. Patient recovered.

Etoposide Side Effects Report #5608087-5
Etoposide side effect was reported by a Physician from UNITED STATES on Jan 29, 2008. Male patient, 55 years of age, weighting 185.2 lb, was treated with Etoposide. After drug was administered, patient experienced the following side effects: dyspnoea, pleuritic pain, pneumonia , pyrexia, renal failure acute, staphylococcal bacteraemia, staphylococcal sepsis. Etoposide dosage: unknown. During the same period patient was treated with CARBOPLATIN, NEULASTA, CISPLATIN. Patient was hospitalized. Patient recovered.

Etoposide Side Effects Report #5669591-7
Etoposide side effect was reported by a Physician from UNITED STATES on Mar 12, 2008. Male patient, 55 years of age, weighting 185.2 lb, was treated with Etoposide. After drug was administered, patient experienced the following side effects: dyspnoea, pleuritic pain, pneumonia , pyrexia, renal failure acute, staphylococcal bacteraemia, staphylococcal sepsis. Etoposide dosage: unknown. During the same period patient was treated with CARBOPLATIN, NEULASTA, CISPLATIN. Patient was hospitalized. Patient recovered.

Etoposide Side Effects Report #5807525-2
Etoposide side effect was reported by a Pharmacist from UNITED STATES on July 09, 2008. Male patient, 54 years of age, was treated with Etoposide. After drug was administered, patient experienced the following side effects: anaemia, cough, dyspnoea, fatigue, leukopenia, neutropenia. Etoposide dosage: 221 MG ONCE IV. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Etoposide Side Effects Report #5448643-0
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 07, 2007. Male patient, 30 years of age, was treated with Etoposide. After drug was administered, patient experienced the following side effects: chest discomfort, chest pain , dyspnoea, erythema, flushing, tachycardia. Etoposide dosage: 100 MG-PT RECEIVED 26 MG. Patient was hospitalized. Patient recovered.


Etoposide Side Effects Report #5669042-2
Etoposide side effect was reported by a Pharmacist from UNITED STATES on Mar 13, 2008. Female patient, weighting 198.4 lb, was treated with Etoposide. After drug was administered, patient experienced the following side effects: dyspnoea, erythema, infusion related reaction, pharyngeal oedema. Etoposide dosage: unknown. Patient recovered.

Etoposide Side Effects Report #5684235-6
Etoposide side effect was reported by a Pharmacist from UNITED STATES on Mar 27, 2008. Female patient, weighting 212.7 lb, was treated with Etoposide. After drug was administered, patient experienced the following side effects: chest discomfort, dyspnoea, nausea , rales, swelling, throat tightness, wheezing. Etoposide dosage: unknown. Patient recovered.

Etoposide Side Effects Report #4609571-3
Etoposide side effect was reported by a Consumer or non-health professional from on Mar 14, 2005. Female patient, weighting 127.9 lb, was treated with Etoposide. After drug was administered, patient experienced the following side effects: cardiac failure, dilatation ventricular, dyspnoea, dyspnoea exertional, ejection fraction decreased, enterococcal infection, fatigue, gallop rhythm present. Etoposide dosage: unknown. During the same period patient was treated with CYTARABINE. Patient recovered.

Etoposide Side Effects Report #4710814-6
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on July 06, 2005. Male patient, weighting 233.7 lb, was treated with Etoposide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood urea increased, breath sounds abnormal, dyspnoea, haemoglobin abnormal, heart rate increased, hypotension. Etoposide dosage: unknown. During the same period patient was treated with CISPLATIN, TAXOTERE. Patient died on 06/26/2005.

Etoposide Side Effects Report #4783458-8
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 28, 2005. Male patient, weighting 153.2 lb, was treated with Etoposide. After drug was administered, patient experienced the following side effects: dyspnoea, loss of consciousness. Etoposide dosage: unknown. During the same period patient was treated with CISPLATIN. Patient died on 09/21/2005.


Etoposide Side Effects Report #4893401-9
Etoposide side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 25, 2006. Female patient, weighting 116.2 lb, was treated with Etoposide. After drug was administered, patient experienced the following side effects: arthralgia, bedridden, chest pain , confusional state, dyspnoea, mental status changes, oral intake reduced, performance status decreased, pseudomonal sepsis. Etoposide dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient died.